No Data
Valiant Co., Ltd (002643.SZ): has currently developed PEEK laboratory samples.
Gelunhui News on November 6th | Valiant Co.,Ltd (002643.SZ) stated on the investor interaction platform that the company has initiated the research and development of PEEK (polyetheretherketone) and other series of products. This material downstream can be used in the fields of electronics, transportation, aviation, medical, etc. Currently, laboratory samples of PEEK have been developed. The research and initial downstream promotion of this product are actively progressing.
Valiant Co., Ltd (002643) Corporate News: Smooth progress of new materials projects driving long-term growth of the company.
Investment highlights: With the decline in demand for eco-friendly materials downstream, the company's quarterly revenue in Q3 2024 decreased compared to the previous quarter. The company achieved a revenue of 2.763 billion yuan in the first three quarters of 2024, a year-on-year decrease of -13.01%; achieving a net income attributable to the parent company of 2.9 billion yuan.
Valiant Co.,Ltd (002643) 2024 Third Quarter Report Review: Pressure on demand for zeolite and pharmaceutical products, bullish on long-term growth prospects
Summary of this report: The performance in Q3 2024 basically meets expectations, oled, and semiconductor manufacturing materials are expected to enter a period of accelerated growth, we are bullish on the long-term growth of the company, maintaining a "shareholding" rating. Investment highlights: Maintaining a "shareholding" rating. Considering
Valiant Co.,Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Valiant Co., Ltd (002643): The revenue performance in Q3 of 2024 is under pressure. The focus is on the layout of electronic information materials.
On the evening of October 29, the company released the third quarter report for 2024. In the first three quarters of 2024, the company achieved a total operating income of 2.763 billion yuan, a 13.01% year-on-year decrease; achieving a net income attributable to the parent company of 0.296 billion yuan.
Valiant Co., Ltd (002643): Decrease in sales of zeolite materials leads to a decrease in profits compared to the previous period.
1-3Q24 performance below our expectations Valiant Co., Ltd. announced 1-3Q24 performance: revenue 2.763 billion yuan, a 13% year-on-year decrease, mainly due to soft demand resulting in decreased revenue from zeolite molecular sieves, life sciences, and pharmaceutical business.
No Data
No Data